|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.96 CNY | +0.52% |
|
+2.40% | -10.92% |
| Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Tech Sector Galvanizes Asian Stock Markets | MT |
Liaoning Chengda Biotechnology Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1,750.1 million compared to CNY 1,815 million a year ago. Net income was CNY 468.45 million compared to CNY 714.02 million a year ago.
Basic earnings per share from continuing operations was CNY 1.13 compared to CNY 1.71 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.92% | 1.65B | |
| -2.72% | 88.91B | |
| +2.76% | 41.25B | |
| -13.92% | 31.99B | |
| +50.51% | 24.73B | |
| -15.25% | 15.54B | |
| -39.93% | 12.07B | |
| -9.08% | 12.05B | |
| -14.80% | 12.02B | |
| +6.22% | 8.84B |
LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD. 
